Joshua Boger, Joseph Scodari, Andrew Baum, Mark Skaletsky, Francois Gauvin, John Elton, Glen Giovanetti, Scott Sarazen | GenomeWeb
The Biotechnology Industry Organization elected new board members last week in conjunction with its annual international convention:
  • Joshua Boger, chairman, president, and CEO of Vertex Pharmaceuticals, was elected chairman of the board. He succeeds James Mullen, CEO of Biogen.
  • Joseph Scodari, worldwide chairman of Johnson & Johnson’s Pharmaceuticals group, was named vice chair of healthcare.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.